Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Shareholders??? Equity (Tables)

v3.24.1
Shareholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2023
Shareholders’ Equity [Abstract]  
Schedule of Stock Option Activity A summary of the stock option activity under the Company’s equity plans during the years ended December 31, 2023, 2022 and 2021 is as follows:
   

Outstanding

share options

    Weighted-average exercise
price ($)
    Weighted average remaining contractual
life (years)
    Aggregate intrinsic value ($ in thousands)  
Options:                        
                         
Outstanding as of December 31, 2020     3,768,034       0.767       4.626       119,146  
                                 
Granted     1,966,916       7.250                  
Forfeited     (117,863 )     0.972                  
Exercised     (155,750 )     0.602                  
                                 
Outstanding as of December 31, 2021     5,461,337       3.102       5.363       16,713,971  
                                 
Granted     1,630,142       6.833                  
Forfeited     (468,814 )     5.557                  
Exercised     (570,451 )     0.482                  
                                 
Outstanding as of December 31, 2022     6,052,214       4.166       5.570       7,761,705  
                                 
Granted     430,874       2.728                  
Forfeited     (351,671 )     7.767                  
Exercised     (1,074,162 )     0.654                  

 

Outstanding as of December 31, 2023

    5,057,255       4.543       5.662       2,352,517  
                                 
Exercisable as of December 31, 2023     3,210,191       3.643       4.403       2,277,303  
                                 
Options available for future grants     611,246                          

 

Schedule of RSUs Activity A summary of the Company’s RSUs activity during the years ended December 31, 2023, 2022 and 2021 is as follows:
    Numbers of RSUs  
RSUs:      
       
Outstanding as of January 1, 2021     -  
         
Granted     1,968,794  
Forfeited     -  
Vested     -  
Outstanding as of December 31, 2021     1,968,794  
         
Granted     1,619,898  
Forfeited     (417,025 )
Vested     (573,583 )
         
Outstanding as of December 31, 2022     2,598,084  
         
Granted     2,908,983  
Forfeited     (370,067 )
Vested     (895,170 )
         
Outstanding as of December 31, 2023     4,241,830  
Schedule of Compensation to Employees The following table sets forth the parameters used in computation of the options compensation to employees and service providers:
   

Year ended

December 31

 
    2023     2022     2021  
                   
Expected term, in years     5.82       4.41-6.11       4.61-6.11  
Expected volatility     47%-51.75%       47%-48%       42%-46%  
Risk-free interest rate     4.15%-4.55%       1.74%-3.96%       0.49%-1.28%  
Expected dividend yield     0%     0%     0%

 

Schedule of Share Based Compensation Expense The following table presents stock-based compensation expense to employees included in the Company’s consolidated statements of operations:
   

Year ended

December 31,

 
    2023     2022     2021  
                   
Research and development   $ 8,721     $ 5,726     $ 1,518  
Sales and marketing     2,229       1,403       217  
General and administrative     1,786       1,537       419  
Cost of revenues     276       127       57  
Total stock-based compensation expense   $ 13,012     $ 8,793     $ 2,211